Nations Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,076
Closed -$250K – 521
2021
Q4
$250K Sell
4,076
-1,494
-27% -$103K 0.03% 423
2021
Q3
$416K Buy
5,570
+450
+9% +$37.8K 0.06% 297
2021
Q2
$474K Buy
5,120
+677
+15% +$57.6K 0.08% 263
2021
Q1
$394K Buy
4,443
+1,091
+33% +$108K 0.09% 252
2020
Q4
$313K Buy
+3,352
New +$267K 0.08% 254

Other funds holding ARKG

Nations Financial Group's ARKG Position: Q1 2022 in Review

Nations Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 4,076 shares — an estimated $250K sold.

Nations Financial Group first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $474K in Q2 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Nations Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Nations Financial Group sold 4,076 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $250K.
  • Nations Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
  • Nations Financial Group's ARK Genomic Revolution ETF position peaked at $474K in Q2 2021.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Nations Financial Group's 13F filing for Q1 2022, filed 13 May 2022.